Inhaled Heparin for Hospitalised COVID-19 Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

485

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

November 1, 2023

Study Completion Date

January 18, 2025

Conditions
Covid19
Interventions
DRUG

Unfractionated heparin

Inhaled nebulised 6 hourly

Trial Locations (5)

Unknown

San Camilo Clinic, Buenos Aires

15th May hospital, Cairo

RS Universitas Indonesia, Depok

RSUP Dr Cipto Mangunkusumo, Jakarta

RSUD Dr Moewardi, Surakarta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Helwan University

OTHER

collaborator

Clinica San Camilo, Argentina

OTHER

collaborator

Frederick Health

OTHER

collaborator

Dr Cipto Mangunkusumo General Hospital

OTHER

collaborator

Dr. Moewardi General Hospital, Surakarta, Indonesia

OTHER

collaborator

University of Sao Paulo

OTHER

collaborator

St James Connolly Memorial Hospital

OTHER

collaborator

University College Hospital Galway

OTHER

collaborator

Beaumont Hospital

OTHER

lead

Australian National University

OTHER